tiprankstipranks
180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market

180 Life Sciences (ATNF) Income Statement

Compare
281 Followers

180 Life Sciences Income Statement

Last quarter (Q3 2024), 180 Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, 180 Life Sciences's net income was $-836.72K. See 180 Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -105.67K$ -109.00K$ -116.30K$ -125.33K$ -72.24K
Operating Expenses
$ 13.48M$ 39.64M$ 20.16M$ 9.82M$ 25.22M
Depreciation and Amortization
$ 105.67K$ 109.00K$ 116.30K$ 125.33K$ 72.24K
EBITDA
$ -22.13M$ -17.79M$ -20.05M$ -5.52M$ -20.79M
Operating Income
$ -13.48M$ -17.90M$ -15.64M$ -5.65M$ -20.86M
Other Income/Expenses
$ -8.81M$ -21.77M-$ -5.26M$ -4.54M
Pretax Income
$ -22.28M$ -39.67M$ -20.35M$ -10.90M$ -25.40M
Net Income
$ -19.94M$ -38.73M$ -20.32M$ -12.01M$ -25.39M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -52.60$ -387.26$ -247.86$ -255.46$ -875.66
Diluted EPS
$ -52.59$ -387.18$ -246.32$ -251.32$ -874.45
Weighted Average Shares Outstanding
379.00K 100.00K 82.00K 47.00K 29.00K
Weighted Average Shares Outstanding (Diluted)
379.09K 100.02K 82.51K 47.77K 29.04K
Currency in USD

180 Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis